STEBVax

Drug Profile

STEBVax

Alternative Names: SEB vaccine - Integrated Biotherapeutics; Staphylococcal enterotoxin B vaccine - Integrated Biotherapeutics

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator United States Army Medical Research Institute of Infectious Diseases
  • Developer Integrated BioTherapeutics; United States Army Medical Research Institute of Infectious Diseases
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Septic shock

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Septic-shock(In volunteers) in USA (IM, Injection)
  • 28 Feb 2011 Phase-I clinical trials in Septic shock (In volunteers) in USA (IM, Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top